Circulating steroid hormone variations throughout different stages of prostate cancer
Supplementary Data
- Supplementary Table 1 - Supplementary Table (PDF 1466 KB)
This Article
-
Endocr Relat Cancer November 1, 2017 vol. 24 no. 11 R403-R420
- AbstractFree
- Figures Only
- Full Text
- Full Text (PDF)
- Supplementary Data
Most
-
Viewed
- Association of Hashimoto's thyroiditis with thyroid cancer
- p53 and breast cancer, an update
- Insulin resistance and cancer: the role of insulin and IGFs
- Progesterone metabolites in breast cancer
- The emerging roles of DNA methylation in the clinical management of prostate cancer
-
Cited
- Fibroblast growth factors, their receptors and signaling
- The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification
- BRAF mutation in thyroid cancer
- mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer
- Discovery of a novel Raf kinase inhibitor
